Top Abstract Purchase Related
Home
>
Node
>
Subnode

Combination therapy of murine tumors with a degraded D-manno-D-glucan (DMG) from Microellobosporia grisea, and cyclophosphamide

Nakajima, H.; Hashimoto, S.; Kita, Y.; Takashi, T.; Tsukada, W.; Kohno, M.; Ogawa, H.; Abe, S.; Mizuno, D.

Japanese Journal of Experimental Medicine 53(6): 263-269

1983

ISSN/ISBN: 0021-5031
PMID: 6240552
Document Number: 201022
DMG, a degraded D-manno-D-glucan with a host-mediated antitumor activity did not significantly enhance nor inhibit the development of suppressor cells for either the antibody-forming response or the delayed hypersensitivity reaction to sheep red blood cells. Cyclophosphamide (CY), which inhibited the generation of suppressor cells, was combined with DMG in treatment of murine syngeneic tumors to obtain a higher antitumor activity. The antitumor activity of the combination against MH134 hepatoma was synergistically higher than that of either component alone. A marked antitumor effect of the combination treatment against MM46 mammary carcinoma was also shown. High levels of antitumor delayed hypersensitivity reactions were observed with this combination therapy. The possible roles of DMG and CY in this combination therapy are discussed.

Document emailed within 1 workday
Secure & encrypted payments

Nahabedian, M.Y.; Cohen, R.A.; Contino, M.F.; Terem, T.M.; Wright, W.H.; Berns, M.W.; Wile, A.G. 1988: Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors Journal of the National Cancer Institute 80(10): 739-743
Drings, P.; Osswald, H. 1975: Synergistic effect of nucleoside and cyclophosphamide combination in murine L 1210 leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1109-1111
Campbell, M.J.; Esserman, L.; Levy, R. 1988: Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide Journal of Immunology 141(9): 3227-3233
Mukai, M.; Ando, K.; Koike, S.; Ishikawa, T.; Ryu, M.; Nagashima, T.; Nagao, K.; Isono, K. 1986: Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 1): 556-562
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
Tohamy, A.A.; El-Ghor, A.A.; El-Nahas, S.M.; Noshy, M.M. 2003: Beta-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin Mutation Research 541(1-2): 45-53
Herman, T.S.; Jones, S.E.; McMahon, L.J.; Lloyd, R.E.; Heusinkveld, R.S.; Miller, R.C.; Salmon, S.E. 1977: Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung Cancer Treatment Reports 61(5): 875-879
Jamali, J.; Dayo, A.; Adeel, A.; Qureshi, Y.; Khan, T.; Begum, S. 2018: A survey on gastrointestinal adverse drug reactions of Doxorubicin and Cyclophosphamide combination therapy JPMA. Journal of the Pakistan Medical Association 68(6): 926-928
Bodey, G.P.; Rodriguez, V.; Hart, J.; Freireich, E.J. 1970: Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271) Cancer ChemoTherapy Reports 54(4): 255-262
Jazowiecka-Rakus, J.; Jarosz, M.; Szala, Sław. 2006: Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours Acta Biochimica Polonica 53(1): 199-202
Abeloff, M.D.; Ettinger, D.S. 1977: Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy Cancer Treatment Reports 61(9): 1685-1689
Crispens, C.G.; Sorenson, J.R. 1990: Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice In Vivo 4(5): 321-323
Pajtasz-Piasecka, E.; Kuśnierczyk, H.; Salwa, J.; Konarski, L.; Radzikowski, C. 1995: Growth inhibition of transplantable tumors in mice by mIL-2-secreting murine plasmocytoma cells used alone or in combination with a cytostatic agent Archivum Immunologiae et Therapiae Experimentalis 43(5-6): 281-292
Patchen, M.L.; Lotzová, E. 1982: Effects of glucan on murine b-lymphocyte colony forming cells Biomedicine and PharmacoTherapy 36(6-7): 316-319
Pospísil, M.; Vacek, A.; Hofer, M.; Viklická, S.; Pipalová, I.; Sandula, J. 1993: Hyporesponsiveness of murine myeloid progenitor cells to glucan following its repeated administration Folia Biologica 39(4): 178-187
Shen, Z.; Chen, Z.; Wang, Y.; Zhang, J.; Zhou, H. 2003: Clonal growth of stoloniferous herb Potentilla anserina on degraded and non-degraded alpine meadow soil Ying Yong Sheng Tai Xue Bao 14(8): 1332-1336
den Haan, J; Visser, P M.; Ganase, A E.; Gooren, E E.; Stal, L J.; van Duyl, F C.; Vermeij, M J. A.; Huisman, J 2014: Nitrogen fixation rates in algal turf communities of a degraded versus less degraded coral reef Coral Reefs 33(4): 1003-1015
Nikitin, E.A.; Stadnik, E.A.; Lorie, I.I.; Biderman, B.V.; Tsyba, N.N.; Salogub, G.N.; Kolosheĭnova, T.I.; Kolosova, L.I.; Risinskaia, N.A.; Zaritskiĭ, I.A.; Kovaleva, L.G.; Sudarikov, A.B. 2007: Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide Terapevticheskii Arkhiv 79(7): 66-70
Takatsuka, Y.; Katoh, T.; Tsumura, I.; Kobayakawa, K.; Kawahara, T. 1992: Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(1): 107-110
Nara, N.; Jinnai, I.; Bessho, M.; Hirashima, K. 1984: Effect of combination therapy of specific active immunization and aclacinomycin-A on murine myeloid leukemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 47(6): 1280-1286